COURTNEY BURNS: Open Payments
NPI 1487052999 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 42 payments from 12 companies in 2025. Trend: 2023 $538 · 2024 $705 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $246 |
| PFIZER INC. | 11 | $223 |
| ABBVIE INC. | 16 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| SHIELD THERAPEUTICS INC | 1 | $33 |
| SANOFI PASTEUR INC. | 2 | $32 |
| Lilly USA, LLC | 1 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: FARXIGA, AIRSUPRA, ZAVZPRET, CAPLYTA, NURTEC ODT, VRAYLAR, REXULTI, UBRELVY.
Industry payments across OK — which companies pay providers there.
